Quantcast

Posts related to ‘ALNY’

Biotechs Bucking The Dendreon Trap & Curse (DNDN, VRTX, VVUS, ARNA, ALNY, AMGN, SVNT)

Posted: May 8, 2012 at 1:15 pm

When we issued our earnings previews for the week ahead, it looked as though Dendreon Corporation (NASDAQ: DNDN) had a chance of really setting the trend for the entire biotech ...
Read Full Story »

Top Analyst Upgrades & Downgrades (ACM, ALNY, BIIB, BP, COF, SNP, CTSH, EA, EPB, ERJ, F, LPX, MFC, MM, RAX, SYNC, VRTX, WYNN)

Posted: May 8, 2012 at 8:11 am

These are some of the top analyst upgrades, downgrades and initiations seen in Wall Street research calls this Tuesday. AECOM Technology Corporation (NYSE: ACM) Cut to Underperform at BofA/ML. Alnylam ...
Read Full Story »

24/7 Wall St. Closing Bell (DELL, KMB, SWY, RAX, BAC, ANF, CMCSA, XEC, DE, DVN, INCY, NOR, TEVA, ZNGA, BPAX, CSKI, IPSU, ALNY, CYBI)

Posted: February 15, 2012 at 4:07 pm

The three major US stock indexes opened slightly higher this morning, but the DJIA almost immediately turned south and remained in negative territory all session. The Nasdaq composite and S&P ...
Read Full Story »

BioWatch: Biotechs With 50% Implied Upside (GENZ, CEPH, ALNY, DNDN, GERN, HALO, VVUS)

Posted: March 30, 2011 at 10:48 am

Biotech is about to become even less of a diversified sector due to mergers and acquisitions. Genzyme Corporation (NASDAQ: GENZ) and Cephalon Inc. (NASDAQ: CEPH) will end up accounting for ...
Read Full Story »

Biotech Business Daily (BIIB, VRTX, ALNY, STEM)

Posted: July 10, 2009 at 10:07 am

Here are some of the top stories affecting key drug and biotech stocks this Friday.  We also have links through to more detailed coverage and analysis at BioHealthInvestor.com: Biogen Idec ...
Read Full Story »

Biotech Business Daily (RIGL, BIIB, ARRY, ALNY, FOLD, HALO, AOB, STEM)

Posted: July 9, 2009 at 11:09 am

Here are some of the top stories affecting key drug and biotech stocks that have links through to more in-depth coverage and analysis today at the website BioHealthInvestor.com: Rigel Pharmaceuticals ...
Read Full Story »

BioHealth Business Daily (CI, AET, MYL, JAZZ, PTIE, GSK, ALNY, FOLD, HALO, AOB, STEM)

Posted: July 7, 2009 at 11:03 am

Here are some of the top stories affecting key drug and biotech stocks that are covered in-depth today at BioHealthInvestor.com: Cigna corp. (NYSE: CI), Aetna Inc. (NYSE: AET), and other ...
Read Full Story »
biotech

The Five Growth Biotech Names To Watch Right Now

Posted: July 6, 2009 at 4:27 am

Alnylam (Nasdaq: ALNY) leads a short list of some of the fastest-growing biotech stocks where analyst estimate revisions continue to rise. BioHealth Investor began by analyzing 171 stocks in the ...
Read Full Story »

Top Analyst Upgrades (ALNY, DB, DSCM, ZEUS, SEPR, X, YHOO)

Posted: June 10, 2009 at 6:58 am

These are some of the top pre-market analyst upgrades and positive research calls we have seen from Wall Street research calls early this Wednesday morning: Alnylam (ALNY) Started as Buy ...
Read Full Story »

Early-Bird Analyst Downgrades (AAP, ALNY, COMV, DISH, DPS, HAS, NATI, NVTL, STEL)

Posted: August 20, 2008 at 6:32 am

These are some of the early analyst downgrades or negative calls we are seeing this Wednesday in early pre-market hours:Advance Auto Parts (AAP) Cut to Neutral at JPMorgan.Alnylam Pharma (ALNY) ...
Read Full Story »
Alnylam_logo

Alnylam Cancels Conference… What’s Brewing? (ALNY)

Posted: August 4, 2008 at 4:15 pm

We just saw a report out of Alnylam Pharmaceuticals Inc. (NASDAQ: ALNY) that may get traders moving on both sides of the stock.  The company has just announced that management ...
Read Full Story »

Today in Biotech Stocks (ALNY, ARIA, CEPH, CYPB, GTCB, ITMN)

Posted: February 8, 2008 at 12:32 pm

Below are some of the news items affecting shares of biotech stocks:Alnylam Pharmaceuticals Inc. (NASDAQ: ALNY) is enjoying upgrades after a positive earnings release Thursday. The company’s partnership with Swiss ...
Read Full Story »

Alnylam Pharmaceuticals (ALNY): A Big Break

Posted: July 9, 2007 at 8:39 am

Alnylam Pharmaceuticals (ALNY), an RNAi therapeutics company, has signed a huge license with Roche which could be worth as much as $1 billion The small company had total revenue fo ...
Read Full Story »